FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal Trade Commission (FTC) uncovered in its second interim staff report rele | The FTC released its second interim staff report Tuesday during Chair Lina Khan's final open commission meeting,
House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...
The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...
The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...
CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Congress missed a chance at PBM reforms.
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback